Cargando…
Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
Cancer stem cells (CSCs), also known as tumor-initiating cells (TICs), are suggested to be responsible for drug resistance and cancer relapse due in part to their ability to self-renew themselves and differentiate into heterogeneous lineages of cancer cells. Thus, it is important to understand the c...
Autores principales: | Phi, Lan Thi Hanh, Sari, Ita Novita, Yang, Ying-Gui, Lee, Sang-Hyun, Jun, Nayoung, Kim, Kwang Seock, Lee, Yun Kyung, Kwon, Hyog Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850899/ https://www.ncbi.nlm.nih.gov/pubmed/29681949 http://dx.doi.org/10.1155/2018/5416923 |
Ejemplares similares
-
Hedgehog Signaling in Cancer: A Prospective Therapeutic Target for Eradicating Cancer Stem Cells
por: Sari, Ita Novita, et al.
Publicado: (2018) -
20(R)-Ginsenoside Rg3 Influences Cancer Stem Cell Properties and the Epithelial-Mesenchymal Transition in Colorectal Cancer via the SNAIL Signaling Axis
por: Phi, Lan Thi Hanh, et al.
Publicado: (2019) -
The anti‐metastatic effect of ginsenoside Rb2 in colorectal cancer in an EGFR/SOX2‐dependent manner
por: Phi, Lan Thi Hanh, et al.
Publicado: (2018) -
Interferon‐induced transmembrane protein 1‐mediated EGFR/SOX2 signaling axis is essential for progression of non‐small cell lung cancer
por: Yang, Ying‐Gui, et al.
Publicado: (2018) -
Interferon-induced transmembrane protein 1 (IFITM1) is required for the progression of colorectal cancer
por: Sari, Novita Ita, et al.
Publicado: (2016)